Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

<p>Abstract</p> <p>Background</p> <p>In resource-limited settings where nevirapine-containing regimen is the preferred regimen in women, data on severe adverse events (SAEs) according to CD4 cell count are limited. We estimated the incidence of SAEs according to CD4 cell count and identify their ris...

詳細記述

書誌詳細

主要な著者:	Amani-Bosse Clarisse, Tanon Aristophane K, Tonwe-Gold Besigin, Coffie Patrick A, Bédikou Gédéon, Abrams Elaine J, Dabis François, Ekouevi Didier K
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2010-06-01
シリーズ:	BMC Infectious Diseases
オンライン･アクセス:	http://www.biomedcentral.com/1471-2334/10/188
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!